Cita APA

Anthony, D., Sibson, N., Losey, P., Piani, D., & Leppert, D. (2009). Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis.

Citación estilo Chicago

Anthony, D., N. Sibson, P. Losey, D. Piani, and D. Leppert. Oral Fingolimod (FTY720) Therapy Reduces Blood Brain Barrier Breakdown, Microglial Activation, and Leukocyte Recruitment in a Focal DTH Model of Multiple Sclerosis. 2009.

Cita MLA

Anthony, D., et al. Oral Fingolimod (FTY720) Therapy Reduces Blood Brain Barrier Breakdown, Microglial Activation, and Leukocyte Recruitment in a Focal DTH Model of Multiple Sclerosis. 2009.